Category
All
New Technology
Service & Software
Internet & Communication
Electronics & Semiconductor
Pharma & Healthcare
Other
Energy & Power
Agriculture
Consumer Goods
Machinery & Equipment
Food & Beverages
Medical Care
Automobile & Transportation
Packaging
Chemical & Material
Medical Devices & Consumables
Category
All
Total: 4 records, 1 pages
Search For: Glucagon-like Peptide-2 (GLP-2) Agonist
Global Glucagon-like Peptide-2 (GLP-2) Agonist Supply, Demand and Key Producers, 2024-2030
18 Feb 2024
Pharma & Healthcare
Glucagon-like Peptide-2 (GLP-2) Agonist
The global Glucagon-like Peptide-2 (GLP-2) Agonist market size is expected to reach $ 2094.9 million by 2030, rising at a market growth of 15.3% CAGR during the forecast period (2024-2030).
USD4480.00
Add To Cart
Global Glucagon-like Peptide-2 (GLP-2) Agonist Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
09 Jan 2024
Pharma & Healthcare
Glucagon-like Peptide-2 (GLP-2) Agonist
According to our (Global Info Research) latest study, the global Glucagon-like Peptide-2 (GLP-2) Agonist market size was valued at USD 772.7 million in 2023 and is forecast to a readjusted size of USD 2094.9 million by 2030 with a CAGR of 15.3% during review period.
USD3480.00
Add To Cart
Global Glucagon-like Peptide-2 (GLP-2) Agonist Supply, Demand and Key Producers, 2023-2029
25 Feb 2023
Pharma & Healthcare
Glucagon-like Peptide-2 (GLP-2) Agonist
The global Glucagon-like Peptide-2 (GLP-2) Agonist market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
USD4480.00
Add To Cart
Global Glucagon-like Peptide-2 (GLP-2) Agonist Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
09 Jan 2023
Pharma & Healthcare
Glucagon-like Peptide-2 (GLP-2) Agonist
Teduglutide (brand names Gattex in the US and Revestive in Europe) is a 33-membered polypeptide and glucagon-like peptide-2 (GLP-2) analog that is used for the treatment of short bowel syndrome.
USD3480.00
Add To Cart
Popular Product Keywords
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
Search For: Glucagon-like Peptide-2 (GLP-2) Agonist
Total: 4 records, 1 pages
The global Glucagon-like Peptide-2 (GLP-2) Agonist market size is expected to reach $ 2094.9 million by 2030, rising at a market growth of 15.3% CAGR during the forecast period (2024-2030).
USD4480.00
Add To Cart
According to our (Global Info Research) latest study, the global Glucagon-like Peptide-2 (GLP-2) Agonist market size was valued at USD 772.7 million in 2023 and is forecast to a readjusted size of USD 2094.9 million by 2030 with a CAGR of 15.3% during review period.
USD3480.00
Add To Cart
The global Glucagon-like Peptide-2 (GLP-2) Agonist market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
USD4480.00
Add To Cart
Teduglutide (brand names Gattex in the US and Revestive in Europe) is a 33-membered polypeptide and glucagon-like peptide-2 (GLP-2) analog that is used for the treatment of short bowel syndrome.
USD3480.00
Add To Cart
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>